iBio Announces Manufacturing Collaboration with Aethlon Medical

Read Press Release

Latest Financial Results

2017

Year End Results

Jun 30, 2017
Further recent Filings may be viewed in SEC Filings.

Stock Information

iBio Inc. NYSE American: IBIO
Price Loading...
Change Loading...
Market Cap Loading...
Volume Loading...

Company Overview

iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.

The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.

View Profile